Skip to main content

Healthy Adult Volunteer

3
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
3
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Daewon Pharma
Daewon PharmaKorea - Hwaseong
2 programs
2
DW4421Phase 11 trial
DW4421-T1Phase 11 trial
Active Trials
NCT07364877Enrolling By Invitation38Est. May 2026
NCT07364851Not Yet Recruiting38Est. Aug 2026
Hanmi Pharmaceutical
1 program
1
HIP2101Phase 11 trial
Active Trials
NCT04967014Completed32Est. Jun 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Daewon PharmaDW4421-T1
Daewon PharmaDW4421
Hanmi PharmaceuticalHIP2101

Clinical Trials (3)

Total enrollment: 108 patients across 3 trials

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421-T1 and DW4421S-T1 in Healthy Adult Volunteers

Start: Mar 2026Est. completion: Aug 202638 patients
Phase 1Not Yet Recruiting

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421 and DW4421S in Healthy Adult Volunteers

Start: Dec 2025Est. completion: May 202638 patients
Phase 1Enrolling By Invitation

Study to Evaluate the Safety and Pharmacodynamic/Pharmacokinetic Characteristics of HIP2101 in Healthy Volunteers

Start: May 2021Est. completion: Jun 202132 patients
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.